Biofrontera Inc.
BFRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.00M | 10.08M | 17.10M | 6.99M | 9.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.00M | 10.08M | 17.10M | 6.99M | 9.03M |
| Cost of Revenue | 2.41M | 2.12M | 3.01M | 2.05M | 2.64M |
| Gross Profit | 9.59M | 7.97M | 14.09M | 4.94M | 6.39M |
| SG&A Expenses | 9.67M | 11.00M | 8.75M | 10.37M | 10.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.53M | 14.01M | 12.54M | 13.27M | 14.11M |
| Operating Income | -524.00K | -3.93M | 4.56M | -6.28M | -5.08M |
| Income Before Tax | -581.00K | -4.75M | 5.64M | -6.64M | -5.30M |
| Income Tax Expenses | 23.00K | -- | 0.00 | 6.00K | 21.00K |
| Earnings from Continuing Operations | -604.00K | -4.75M | 5.64M | -6.65M | -5.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -604.00K | -4.75M | 5.64M | -6.65M | -5.32M |
| EBIT | -524.00K | -3.93M | 4.56M | -6.28M | -5.08M |
| EBITDA | -459.00K | -3.87M | 4.62M | -6.26M | -5.05M |
| EPS Basic | -0.05 | -0.41 | 0.48 | -0.62 | -0.57 |
| Normalized Basic EPS | -0.03 | -0.25 | 0.26 | -0.39 | -0.35 |
| EPS Diluted | -0.05 | -0.41 | 0.48 | -0.62 | -0.57 |
| Normalized Diluted EPS | -0.03 | -0.25 | 0.26 | -0.39 | -0.35 |
| Average Basic Shares Outstanding | 12.92M | 11.68M | 11.66M | 10.78M | 9.35M |
| Average Diluted Shares Outstanding | 12.92M | 11.68M | 11.66M | 10.78M | 9.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |